Peak enhancement in contrast-enhanced ultrasound for assessing endoscopic disease activity in patients with Crohn’s disease: a meta-analysis

Abstract

Background Contrast-enhanced ultrasound (CEUS) has been proposed as a valuable tool for detecting disease activity in patients with Crohn’s disease (CD). However, previous studies have utilized different parameters, leading to variation in clinical assessment of this technique. Purpose To assess the effectiveness of peak enhancement (PE) in CEUS for evaluating endoscopic disease activity in patients with CD. Material and Methods Articles were obtained by searching PubMed, Embase, Web of Science, Wanfang, and CNKI databases. Only studies that investigated the effectiveness of PE in CEUS to discriminate endoscopic disease activity in patients with CD were considered. Pooled sensitivity and specificity were then calculated using a random effects model. Results Overall, seven studies were included. The endoscopic disease activity of CD was determined based on the simple endoscopic score for Crohn’s disease and Crohn’s Disease Endoscopic Index of Severity scores. Pooled results showed that a high PE was associated with increased detection efficacy for endoscopic disease activity in CD. Pooled sensitivity, specificity, and positive and negative likelihood ratios were 0.88 (95% confidence interval [CI] = 0.71–0.96), 0.88 (95% CI = 0.81–0.93), 7.60 (95% CI = 4.61–12.53), and 0.14 (95% CI = 0.05–0.35), respectively. The pooled receiver operating characteristic was 0.90 (95% CI = 0.87–0.92), suggesting a good discriminating efficacy of PE in CEUS for endoscopic disease activity of patients with CD. Conclusions A high PE in CEUS displayed substantial distinguishing accuracy for assessing endoscopic disease activity of patients with CD.